BetterLife Added to Horizons Psychedelic Stock Index ETF
29. März 2021 08:00 ET
|
BetterLife Pharma
VANCOUVER, March 29, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU) is pleased to announce that it has been added to the...
BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003
11. März 2021 08:00 ET
|
BetterLife Pharma
VANCOUVER, March 11, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), today announced that its wholly-owned subsidiary, Altum...
BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies
08. März 2021 08:00 ET
|
BetterLife Pharma
VANCOUVER, March 08, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development...
BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing
03. März 2021 08:00 ET
|
BetterLife Pharma
VANCOUVER, March 03, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development...
BetterLife to Present at the Emerging Growth Conference on February 17, 2021
16. Februar 2021 07:00 ET
|
BetterLife Pharma
Vancouver, Feb. 16, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce that...
BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder
02. Februar 2021 08:30 ET
|
BetterLife Pharma
Vancouver, Feb. 02, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and...
BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies
28. Januar 2021 02:00 ET
|
BetterLife Pharma
VANCOUVER, Jan. 27, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and...
BetterLife Demonstrates 6 months Refrigerated Stability of its Proprietary Interferon Formulation to be Developed to Treat Early Stage Covid-19 Cases
26. Januar 2021 08:30 ET
|
BetterLife Pharma
VANCOUVER, Jan. 26, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and...
BetterLife Selects CRO to Conduct Clinical Trials for AP-003 in COVID-19 Cases in Indonesia
21. Januar 2021 08:30 ET
|
BetterLife Pharma
VANCOUVER, Jan. 21, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and...
BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada
19. Januar 2021 02:00 ET
|
BetterLife Pharma
VANCOUVER, Jan. 18, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and...